Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
This is a protocol for a Cochrane Review (Diagnostic test accuracy).The objectives are as follows:To determine the diagnostic accuracy of Xpert® MTB/RIF for the detection of extrapulmonary TB by site of disease in people suspected of having extrapulmonary TB.The role of Xpert® MTB/RIF would be a replacement for standard practice.To determine the diagnostic accuracy of Xpert® MTB/RIF for detection of rifampicin resistance in people suspected of having extrapulmonary TB.The role of Xpert® MTB/RIF would be an initial test for replacement for culture-based DST.We plan to investigate the impact of covariates on heterogeneity in estimates of test accuracy across the included studies. Detection of extrapulmonary TBThe covariates of interest are: HIV prevalence; condition of the specimen (fresh versus frozen); sample input volume (for liquid specimens); homogenization step (for tissue specimens); smear status of specimen; past history of TB; and prevalence of extrapulmonary TB.In addition, we plan to explore whether the WHO standard operating procedures for a given type of specimen were followed and can explain the observed heterogeneity in accuracy estimates.For TB meningitis we plan to investigate whether the use of a concentration step prior to the use of Xpert® MTB/RIF has an impact on accuracy estimates.In addition, for detection of lymph node TB, pleural TB, and TB meningitis, we plan to adjust accuracy estimates by applying a latent class meta-analysis model to account for the imperfect nature of culture as the reference standard. Detection of rifampicin resistance detectionThe covariate of interest is the prevalence of rifampicin resistance. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance (Protocol)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationAssessment of diagnostic tests when disease verification is subject to selection bias
Begg, C. B., & Greenes, R. A. (1983) · Biometrics · doi:10.2307/2530820 · Cited by 708
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
Dinnes, J., Deeks, J., Kunst, H., Gibson, A., Cummins, E., Waugh, N., Drobniewski, F., & Lalvani, A. (2007) · Health Technology Assessment · doi:10.3310/hta11030 · Cited by 666
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Self-citationEvaluation of the analytical performance of the Xpert MTB/RIF assay
Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M. R., Chakravorty, S., Jones, M., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-10 · Cited by 485
Tuberculous meningitis: more questions, still too few answers
Thwaites, G. E., van Toorn, R., & Schoeman, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70168-6 · Cited by 482
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Research works printed but not linked: 40
- American Thoracic Society, 2000, Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999, American Journal Respiratory and Critical Care Medicine, 161, 1376
- Balshem, 2011, GRADE guidelines:3. Rating the quality of evidence, Journal of Clinical Epidemiology, 64, 401-6, 10.1016/j.jclinepi.2010.07.015 · DOI · Paper page
- Banada, 2010, Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings, Journal of Clinical Microbiology, 48, 3551, 10.1128/JCM.01053-10 · DOI · Paper page
- Boyles, 2014, False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results, International Journal Tuberculosis and Lung Disease, 18, 876, 10.5588/ijtld.13.0853 · DOI · Paper page
- Chang, 2012, Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis, Journal of Infection, 64, 580, 10.1016/j.jinf.2012.02.012 · DOI · Paper page
- Chow, 2002, Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples, Clinical Infectious Diseases, 35, 409, 10.1086/341898 · DOI · Paper page
- Chu, 2009, Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard, Journal of the American Statistical Association, 104, 512-23, 10.1198/jasa.2009.0017 · DOI · Paper page
- Denkinger, 2015, Defining the needs for next generation assays for tuberculosis, Journal of Infectious Diseases, 211, S29, 10.1093/infdis/jiu821 · DOI · Paper page
- Diacon, 2003, Diagnostic tools in tuberculous pleurisy: a direct comparative study, European Respiratory Journal, 22, 589, 10.1183/09031936.03.00017103a · DOI · Paper page
- Golden, 2005, Extrapulmonary tuberculosis: an overview, American Family Physician, 72, 1761
- Gopi, 2007, Diagnosis and treatment of tuberculous pleural effusion in 2006, Chest, 131, 880, 10.1378/chest.06-2063 · DOI · Paper page
- Gupta, 2015, Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis, AIDS, 29, 1987, 10.1097/QAD.0000000000000802 · DOI · Paper page
- Hartmann, 1967, The specific inhibition of the DNA-directed RNA synthesis by rifamycin, Biochimica et Biophysica Acta, 145, 843-4
- Iseman, 2000, Extrapulmonary tuberculosis in adults, 145-97
- Kelly, 2014, Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection, American Journal of Respiratory and Critical Care Medicine, 190, 1316, 10.1164/rccm.201408-1500LE · DOI
- Leeflang, 2009, Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis, Journal of Clinical Epidemiology, 62, 5, 10.1016/j.jclinepi.2008.04.007 · DOI · Paper page
- Li, 2017, Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis, PLOS One, 12, e0180725, 10.1371/journal.pone.0180725 · DOI
- Lunn, 2000, WinBUGS -a Bayesian modelling framework: concepts, structure, and extensibility, Statistics and Computing, 10, 325-37, 10.1023/A:1008929526011 · DOI · Paper page
- Macaskill P Gatsonis C Deeks JJ Harbord RM Takwoingi Y Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, C Gatsonis (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration 2010 http://srdta.cochrane.org/
- Maynard-Smith, 2014, Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review, BMC Infectious Diseases, 14, 709, 10.1186/s12879-014-0709-7 · DOI · Paper page
- Miotto, 2012, Early tuberculosis treatment monitoring by Xpert(R) MTB/RIF, European Respiratory Journal, 39, 1269, 10.1183/09031936.00124711 · DOI · Paper page
- Nahid, 2016, Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, Clinical Infectious Diseases, 63, e147, 10.1093/cid/ciw376 · DOI · Paper page
- Nathavitharana, 2017, Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis, European Respiratory Journal, 49, pii: 1601075, 10.1183/13993003.01075-2016 · DOI · Paper page
- Nelson, 2004, Global epidemiology of childhood tuberculosis, International Journal of Tuberculosis and Lung Disease, 8, 636
- Perkins, 2007, Facing the crisis: improving the diagnosis of tuberculosis in the HIV era, Journal of Infectious Diseases, 196, S15-27
- Reuter, 2009, Overview of extrapulmonary tuberculosis in adults and children, 377, 10.1016/B978-1-4160-3988-4.00034-2 · DOI
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
- Sandgren, 2013, Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011, Euro Surveillance, 18, pii: 20431
- Schiller, 2016, Bias due to composite reference standards in diagnostic accuracy studies, Statistics in Medicine, 35, 1454, 10.1002/sim.6803 · DOI · Paper page
- Schumacher, 2016, Diagnostic test accuracy in childhood pulmonary tuberculosis: a Bayesian latent class analysis, American Journal of Epidemiology, 184, 690, 10.1093/aje/kww094 · DOI · Paper page
- Schünemann HJ Oxman AD Gunn EV Higgins JPT Deeks JL Glasziou P Chapter 11. Presenting results and "Summary of findings" tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Sehgal, 2016, Diagnostic Performance of Xpert MTB/RIF in Tuberculous Pleural Effusion: Systematic Review and Meta-analysis, Journal of Clinical Microbiology, 54, 1133, 10.1128/JCM.03205-15 · DOI · Paper page
- Shah, 2016, Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011420.pub2 · DOI · Paper page
- Sharma, 2004, Extrapulmonary tuberculosis, Indian Journal of Medical Research, 120, 316
- Shu, 2011, In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement, BMC Infectious Diseases, 11, 46, 10.1186/1471-2334-11-46 · DOI
- Steingart, 2014, Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009593.pub3 · DOI · Paper page
- TB CARE, 2014, International Standards for Tuberculosis Care
- Telenti, 1993, Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis, Lancet, 341, 647, 10.1016/0140-6736(93)90417-F · DOI · Paper page
- Boyle, 2017, Tuberculosis Diagnostics Technology and Market Landscape
- Smeden, 2014, Latent class models in diagnostic studies when there is no reference standard - a systematic review, Amercian Journal of Epidemiology, 179, 423, 10.1093/aje/kwt286 · DOI · Paper page
Cited by
Schünemann, H. J., Mustafa, R. A., Brozek, J., Steingart, K. R., Leeflang, M., Murad, M. H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.020 · Cited by 405
Self-citationSchünemann, H. J., Mustafa, R. A., Brozek, J., Steingart, K. R., Leeflang, M., Murad, M. H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.021 · Cited by 387
Self-citationXpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Self-citationKohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Self-citationWang, G., Wang, S., Jiang, G., Yang, X., Huang, M., Huo, F., Ma, Y., Dai, G., Li, W., Chen, X., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.02.010 · Cited by 76
Metadata
- Authors
- Kohli, M., Schiller, I., Dendukuri, N., Ryan, H., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-08-22
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4239537957
- Cited by
- 84
- References
- 14
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-08-27)
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- onlinelibrary.wiley.com/termsAndConditions (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. https://app.cochat.ai/papers/10.1002/14651858.cd012768
- The paper
- Kohli, M., Schiller, I., Dendukuri, N., Ryan, H., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2017). Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.